Caribou Biosciences, Inc.
CRBU- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001619856
No open-market purchases or sales by Caribou Biosciences, Inc. insiders were filed in the last 90 days; 137 institutions reported holding it in 13F filings for Q2 2026, worth $84.8M in total; Maverick Capital is the only superinvestor holding it.
Q1 2025 vs. Q4 2024
How the institutions holding Caribou Biosciences, Inc. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Of which not filed for Q1 2025 | Q1 2025 | Change |
|---|---|---|---|---|
| Holders | 133 | 2 | 131 | 0 |
| Shares | 58.3M | 332.7K | 50.3M | −7.68M (−13.3%) |
| Value | $93.1M | $529.0K | $45.8M | −$46.8M (−50.5%) |
2 institutions that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (19)
Institutions that held Caribou Biosciences, Inc. at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Cambridge Investment Research Advisors, Inc. | 612,412 | $559.0K | 0.00% |
| Nuveen, LLC | 330,831 | $302.1K | 0.00% |
| Graham Capital Management, L.P. | 74,225 | $67.8K | 0.00% |
| Acadian Asset Management LLC | 67,725 | $61.0K | 0.00% |
| Ieq Capital, LLC | 58,248 | $53.2K | 0.00% |
| Group One Trading, L.P. | 23,315 | $21.3K | 0.00% |
| CIBC World Markets Corp | 18,255 | $16.7K | 0.00% |
| Wealth Enhancement Advisory Services, LLC | 17,951 | $16.4K | 0.00% |
| Gsa Capital Partners LLP | 17,605 | $16.0K | 0.00% |
| J.W. Cole Advisors, Inc. | 12,004 | $11.0K | 0.00% |
| Chevy Chase Trust Holdings, Inc. | 10,000 | $9.13K | 0.00% |
| Modern Wealth Management, LLC | 10,000 | $9.13K | 0.00% |
| CoreCap Advisors, LLC | 4,476 | $4.09K | 0.00% |
| UMA Financial Services, Inc. | 962 | $879 | 0.00% |
| Tradewinds Capital Management, LLC | 800 | $731 | 0.00% |
| Point72 (DIFC) Ltd | 655 | $598 | 0.00% |
| EverSource Wealth Advisors, LLC | 609 | $556 | 0.00% |
| Coldstream Capital Management Inc | 504 | $461 | 0.00% |
| True Wealth Design, LLC | 3 | $3 | 0.00% |
Sold out (19)
Institutions that held Caribou Biosciences, Inc. at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| FIL Ltd | 860,666 | $1.37M |
| Lynx1 Capital Management LP | 680,189 | $1.08M |
| American Century Companies Inc | 159,822 | $254.1K |
| Verition Fund Management LLC | 140,101 | $222.8K |
| Balboa Wealth Partners | 55,277 | $87.9K |
| Bank of Montreal | 46,728 | $74.3K |
| Diametric Capital, LP | 26,224 | $41.7K |
| MetLife Investment Management | 24,404 | $38.8K |
| Prudential Financial Inc | 20,772 | $33.0K |
| Centric Wealth Management | 16,847 | $26.8K |
| Franklin Resources Inc | 12,411 | $19.7K |
| Beaumont Capital Management, LLC | 11,825 | $18.8K |
| Engineers Gate Manager LP | 11,294 | $18.0K |
| Signaturefd, LLC | 750 | $1.19K |
| Smartleaf Asset Management LLC | 552 | $888 |
| Skopos Labs, Inc. | 362 | $576 |
| Point72 Asia (Singapore) Pte. Ltd. | 19 | $30 |
| NBC Securities, Inc. | 2 | $3 |
| Lazard Asset Management LLC | 298 | $0 |
Not filed for Q1 2025 yet (2)
Institutions that held Caribou Biosciences, Inc. at the end of Q4 2024 and haven't filed a 13F for Q1 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Nuveen Asset Management, LLC | 330,831 | $526.0K |
| Global Retirement Partners, LLC | 1,865 | $2.96K |